Nippon India Nifty Pharma ETF - Growth Plan vs Aditya Birla Sun Life US Treasury 1-3 Year Bond Etfs Fund of Funds-Direct Plan-Growth
NAV, returns and costs — not a recommendation.
 Nippon India Nifty Pharma ETF - Growth Plan |  Aditya Birla Sun Life US Treasury 1-3 Year Bond Etfs Fund of Funds-Direct Plan-Growth | |
|---|---|---|
| NAV | ₹27.1122 | ₹12.9317 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.49% | +12.72% |
| 3 year (p.a.) | +20.35% | +9.62% |
| 5 year (p.a.) | +14.55% | +9.62% |
| Expense ratio | 0.18% | 0.18% |
| Fund size | ₹1,622.31 Cr | ₹72.18 Cr |
| Risk | Very high | — |
| Category | Etfs | Fund of Funds Overseas |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.